Full Report Details at
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research's team of industry experts.
With increasing cost-cutting pressures due to decreasing Research and Development (R&D) productivity, the patent expiries of blockbusters, drying pipelines and stringent regulations of governments, the cost of conducting research in the Western world is increasing and in turn is putting immense financial pressures on the major pharmaceutical companies. On the other hand, Poland is becoming an attractive location for conducting clinical research. Speed of patient recruitment and quality of clinical trial data are two major advantages in Poland. Moreover, improvements in clinical trial regulation could drive the market in the future. Although Poland controls a very small part of the global clinical research, this share is expected to rise in the future as the Western pharmaceuticals have realized the need to outsource the maximum possible amount of R&D work to low-cost countries. With clinical studies occupying the majority of R&D costs, there is a huge opportunity for significant cost savings.
However, developed countries will face several challenges to continue their growth momentum. Legislative drawbacks and a lack of social awareness towards clinical trials will be the major obstacles for companies in Poland. Moreover, increasing competition from other Eastern European countries is also expected to impede the growth of the clinical trial market in Poland.
* The need for outsourcing clinical trials to Poland.
* Trends in clinical trial registration in Poland and a comparative analysis of clinical trial registration in Eastern European countries.
* Analysis of the key drivers that are fueling the growth of the clinical trial market in Poland.
* Analysis of the key infrastructural facilities, clinical research professionals and principal investigators in Poland.
* Analysis of key government regulations in Poland affecting the clinical trial market.
* Study of 12 major CROs operating in Poland.
Reasons to buy
* Compare the key capabilities of major clinical trial service providers with your requirements and optimize your R&D costs.
* Develop market entry and market expansion strategies by identifying the key drivers and challenges in the Polish clinical trials market.
* Develop effective strategies to maximize the advantages in Poland through understanding of the regulatory environment.
* Understand the regulatory structure in Poland and key documents required to register clinical trials in Poland.
Partial Table of Contents:
1 Table of Contents
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Emerging Market for Clinical Trials - Poland - Introduction
2.1 GBI Research Report Guidance
3 Emerging Market for Clinical Trials - Poland - Overview
3.1 The Clinical Research Process- Overview
3.1.1 Drug Discovery
3.1.2 Preclinical Study/Development
3.1.3 Clinical Trials
3.2 Clinical Trial Design and Types
3.2.1 Types of Design
3.3 Role of CROs
3.4 Sponsors of Clinical Trials
3.5 The Need for Outsourcing Clinical Trials
3.5.1 High Risks and Costs Associated With Drug Development
3.5.2 Escalating Costs of Clinical Trials
3.5.3 Global Increase in the Number of Clinical Trials Conducted
3.5.4 Restructuring the R&D
3.5.5 Increased Screening Rates during R&D
3.5.6 Expiring Patents Pressurize Pharmaceutical Companies to Reduce Costs
4 Emerging Market for Clinical Trials - Poland - Clinical Trial Trends
4.1 Clinical Trials Registered Globally
4.2 Clinical Trials Registered in Eastern European Countries
4.3 Analysis of Clinical Trials Registered in Poland
4.3.1 Clinical Trials Registered in 1995-2010
4.3.2 Analysis of Clinical Trials Registered in 2010
4.3.3 Registration of Phase l Clinical Trials
4.3.4 Registration of Phase ll Clinical Trials
4.3.5 Registration of Phase lll Clinical Trials
4.3.6 Registration of Phase lV Clinical Trials
4.3.7 Clinical Trials Registered by Therapeutic Area
4.4 Comparative Analysis of Industry Sponsored Clinical Trials Registered in US Trials Registry in the Eastern Europe Countries
4.5 Analysis of Clinical Trials Registered by MNCs in Poland
4.6 Sites for Industry Sponsored Clinical Trials Worldwide
4.7 Sites for Industry Sponsored Clinical Trials Registered in Eastern European Countries
4.7.1 Number of Registered Sites for Industry Sponsored Clinical Trials (Phase II/III)
4.7.2 Number of Multi-national Sites Registered for Industry Sponsored Trials (Phase II/III)
4.7.3 Number of Local Sites Registered for Industry Sponsored Trials (Phase II/III)
5 Emerging Market for Clinical Trials - Poland - Market Environment Characterization
5.1 Global CRO Market
5.1.1 Pipeline Analysis of Five Major Pharmaceutical Companies
5.2 Clinical Trial Market in Poland
5.3 Key Drivers of Clinical Trials Market in Poland
Full Table of Contents is available at:
About GBI Research
GBI Research provides industry-leading global business intelligence solutions. Their products and services help companies make better business decisions, win business and position themselves more effectively. GBI Research publishes more than 100 research reports each year across a wide range of industries. These reports draw on in-depth primary and secondary research, databases of proprietary in-house data and high quality analysis from their expert teams. GBI Research employs hundreds of highly qualified Analysts across the US, Europe and Asia. View more research from GBI Research at http://www.fastmr.com/
About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.
For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.